Skip to main content
. 2017 Mar 16;7:203. doi: 10.1038/s41598-017-00370-x

Table 2.

Mean visual analogue scale pain scores with standard deviation for each of the 8 questions (Q) in the questionnaire for patients.

Precancer (N = 37) OSCC (N = 124) Recurrence (N = 21) P
Spontaneous intensity 26.73 ± 15.78 29.53 ± 14.80 33.53 ± 17.53 P1 = 0.693 P2 = 0.560
Functional intensity 28.47 ± 16.23 32.73 ± 16.34 37.67 ± 17.19 P1 = 0.561 P2 = 0.430
Spontaneous sharpness 10.40 ± 8.28 15.60 ± 12.85 36.40 ± 15.87 P1 = 0.278 P2 = 0.000
Functional sharpness 14.27 ± 9.29 20.87 ± 13.03 38.87 ± 16.47 P1 = 0.225 P2 = 0.002
Spontaneous aching 10.40 ± 10.72 28.33 ± 14.56 35.73 ± 13.06 P1 = 0.001 P2 = 0.129
Functional aching 14.67 ± 11.91 33.33 ± 13.54 40.93 ± 14.48 P1 = 0.001 P2 = 0.197
Sensitivity to touch 24.67 ± 16.14 44.87 ± 21.13 60.87 ± 19.72 P1 = 0.009 P2 = 0.027
Functional restriction 27.20 ± 15.52 46.20 ± 16.20 59.93 ± 10.81 P1 = 0.001 P2 = 0.014

P1 = recurrence group vs. pre-cancer group. P2 = recurrence group vs. OSSC group.